why choose us

First received: July 06, 2025

Clinical Trial: Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dexmedetomidine

Study Type: INTERVENTIONAL


Official Title: Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure

Brief Summary: Dexmedetomidine is a potent alpha-2 adrenergic receptor agonist.In addition, dexmedetomidine-induced stimulation of the postsynaptic alpha-2 adrenergic receptor on the cerebral blood vessels can cause cerebral vasoconstriction and decrease cerebral blood flow

Read more